Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Classical conditioning of immunological responses in multiple sclerosis during mitoxantrone therapy
2007-001962-34Phase 4Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Nov 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in secondary-progressive multiple sclerosis (SPMS) comparing Mitoxantrone with Placebo methylene blue infusion (2 arms). Primary endpoint: B-cell apoptosis rate. Started Nov 2007; status: completed.
02
Drugs
mitoxantrone
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on 2007-001962-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001962-34.